前列腺癌男性抑郁与死亡风险的关联
瑞典1998-2017年全国180189例前列腺癌男性队列,随访至2018年,9%诊断重性抑郁、36%死亡。校正社会人口学与合并症后,重性抑郁与高危前列腺癌全因死亡HR 1.50(95%CI 1.44-1.55)、低中危HR 1.64(1.56-1.71)相关。
要点
- 180189例前列腺癌男性中16134例(9%)诊断重性抑郁,65643例(36%)死亡。
- 高危前列腺癌合并抑郁全因死亡HR 1.50(95%CI 1.44-1.55),低中危HR 1.64(1.56-1.71)。
- 前列腺癌特异死亡高危HR 1.35(1.28-1.43),低中危HR 1.42(1.27-1.59)。
核心结论
- 在该全国前列腺癌男性队列中,重性抑郁与全因死亡率约升高50%相关。
- 前列腺癌男性需及时识别和治疗抑郁以支持长期结局和生存。
研究设计与样本
- 瑞典全国队列研究,纳入1998-2017年诊断前列腺癌的全部180189例男性。
- 通过全国门诊和住院记录 ascertain 至2018年的重性抑郁诊断,死亡通过全国记录至2018年确认。
- 采用Cox回归计算重性抑郁与全因死亡的风险比(HR),校正社会人口学因素和合并症。
- 亚组分析评估2005-2017年前列腺癌治疗差异,前列腺癌特异死亡采用竞争风险模型。
主要发现
- 随访1.3百万person-years中,16134例(9%)诊断重性抑郁,65643例(36%)死亡。
- 校正后,重性抑郁与高危前列腺癌全因死亡HR 1.50(95%CI 1.44-1.55)相关。
- 重性抑郁与低或中危前列腺癌全因死亡HR 1.64(95%CI 1.56-1.71)相关。
- 重性抑郁与高危前列腺癌前列腺癌特异死亡HR 1.35(95%CI 1.28-1.43)相关。
- 重性抑郁与低或中危前列腺癌前列腺癌特异死亡HR 1.42(95%CI 1.27-1.59)相关。
临床怎么用
- 原文结论指出前列腺癌男性需及时识别和治疗抑郁以支持长期结局和生存。
- 原文患者摘要指出前列腺癌男性需密切监测以识别和治疗抑郁以改善长期健康结局。
局限性
- 本研究仅限于瑞典,需要在其他国家的可行性条件下重复验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Men diagnosed with prostate cancer (PC) have an increased risk of depression; however, it is unclear to what extent depression affects long-term survival. A better understanding of such effects is needed to improve long-term care and outcomes for men with PC. OBJECTIVE: To determine the associations between major depression and mortality in a national cohort of men with PC. DESIGN, SETTING, AND PARTICIPANTS: A national cohort study was conducted of all 180 189 men diagnosed with PC in Sweden during 1998-2017. Subsequent diagnoses of major depression were ascertained from nationwide outpatient and inpatient records through 2018. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Deaths were identified from nationwide records through 2018. Cox regression was used to compute hazard ratios (HRs) for all-cause mortality associated with major depression, adjusting for sociodemographic factors and comorbidities. Subanalyses assessed differences by PC treatment during 2005-2017. PC-specific mortality was examined using competing risks models. RESULTS AND LIMITATIONS: In 1.3 million person-years of follow-up, 16 134 (9%) men with PC were diagnosed with major depression and 65 643 (36%) men died. After adjusting for sociodemographic factors and comorbidities, major depression was associated with significantly higher all-cause mortality in men with high-risk PC (HR, 1.50; 95% confidence interval [CI], 1.44-1.55) or low- or intermediate-risk PC (1.64; 1.56-1.71). These risks were elevated regardless of PC treatment or age at PC diagnosis, except for youngest men (<55 yr) in whom the risks were nonsignificant. Major depression was also associated with increased PC-specific mortality in men with either high-risk PC (HR, 1.35; 95% CI, 1.28-1.43) or low- or intermediate-risk PC (1.42; 1.27-1.59). This study was limited to Sweden and will need replication in other countries when feasible. CONCLUSIONS: In this national cohort of men with PC, major depression was associated with ∼50% higher all-cause mortality. Men with PC need timely detection and treatment of depression to support their long-term outcomes and survival. PATIENT SUMMARY: In this report, we examined the effects of depression on survival in men with prostate cancer. We found that among all men with prostate cancer, those who developed depression had a 50% higher risk of dying than those without depression. Men with prostate cancer need close monitoring for the detection and treatment of depression to improve their long-term health outcomes.
引用
- Crump C, Stattin P, Brooks JD, et al. Mortality Risks Associated with Depression in Men with Prostate Cancer. Eur Urol Oncol. 2024. PMID: 38575410. doi:10.1016/j.euo.2024.03.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。